Curriculum Vitae

ASSOCIATE PROF. DR. RAJA ISKANDAR SHAH RAJA AZWA

Associate Professor
  • Department of Medicine
    Faculty of Medicine
  • +603 79493834

ACADEMIC QUALIFICATION


  • MRCP, UK (2003), (Medicine)
    Royal College of Physicians of Edinburgh, United Kingdom
  • DIP HIV (2008), (Hiv Medicine)
  • DIP GUM (2005), (Genitourinary Medicine)
  • MB CHB, (Medicine and Surgery)
    University of Dundee, UK

ADMINISTRATIVE DUTIES


  • Acting Head of Unit
    03 Oct 2022 - 31 Dec 2022 (Department)
  • Supervisor
    13 Jun 2017 - 19 Jun 2017 (University Malaya)

MEMBERSHIPS


  • PRESIDENT OF THE MALAYSIAN AIDS COUNCIL, PRESIDENT/ CHIEF
    2022 to 2024 (International)
  • AIDS EDITORIAL BOARD MEMBER, EDITORIAL BOARD
    2022 to 2024 (International)
  • UK GENERAL MEDICAL COUNCIL, ACADEMIC MEMBER
    Since 2008 (International)
  • MALAYSIAN AIDS COUNCIL, HONORARY SECRETARY
    2020 to 2022 (National)
  • AIDS EDITORIAL BOARD, EDITORIAL BOARD MEMBER
    2019 to 2021 (International)
  • 4TH ASIA PACIFIC AIDS & CO_INFECTIONS CONFERENCE, CHAIRPERSON FOR PRESENTATION
    2019 to 2019 (International)
  • IAS 2019 SCIENTIFIC PROGRAMME COMMITTEE, OTHERS
    2019 to 2019 (International)
  • UNIVERSITY MALAYA MEDICAL CENTRE TB COMMITTEE, COMMITTEE MEMBER
    2017 to 2019 (University)
  • BKK SYMPOSIUM SCIENTIFIC ORGANIZING COMMITTEE (SOC), COMMITTEE MEMBER
    2019 to present (International)

PUBLICATIONS


Article in Journal
WoS
  1. Ni, Zhao; Shrestha, Roman; Earnshaw, Valerie A. A.; Tee, Ying Chew; Altice, Frederick L. L.; Azwa, Iskandar; Kamarulzaman, Adeeba; Zhou, Xin; Wickersham, Jeffrey A. A. (2023). Exploring Malaysian Physicians' Intention to Discriminate Against Gay, Bisexual, and Other Men Who Have Sex with Men Patients, LGBT HEALTH. . doi:10.1089/lgbt.2021.0452
  2. Boettiger, David C.; Vu Thien An; Kumarasamy, Nagalingeswaran; Azwa, Iskandar; Sudjaritruk, Tavitiya; Truong, Khanh Huu; Avihingsanon, Anchalee; Ross, Jeremy; Kariminia, Azar (2022). Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and Failure, JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 90(2), 193-200. doi:10.1097/QAI.0000000000002931
  3. Eger, William H.; Adaralegbe, Adeleye; Khati, Antoine; Azwa, Iskandar; Wickersham, Jeffrey A.; Osborne, Sydney; Shrestha, Roman (2022). Exploring drivers of pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in Malaysia, INTERNATIONAL JOURNAL OF STD & AIDS. 33(9), 821-828. doi:10.1177/09564624221106535
  4. Han, Win Min; Law, Matthew G.; Choi, Jun Yong; Ditangco, Rossana; Kumarasamy, Nagalingeswaran; Chaiwarith, Romanee; Ly, Penh Sun; Khusuwan, Suwimon; Merati, Tuti Parwati; Cuong Duy Do; Yunihastuti, Evy; Azwa, Iskandar; Lee, Man-Po; Thach Ngoc Pham; Chan, Yu-Jiun; Kiertiburanakul, Sasisopin; Ng, Oon Tek; Tanuma, Junko; Pujari, Sanjay; Zhang, Fujie; Gani, Yasmin; Mave, Vidya; Ross, Jeremy; Avihingsanon, Anchalee (2022). Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV, HIV MEDICINE. . doi:10.1111/hiv.13211
  5. Jiamsakul, Awachana; Gani, Yasmin; Avihingsanon, Anchalee; Azwa, Iskandar; Chaiwarith, Romanee; Khusuwan, Suwimon; Ross, Jeremy; Law, Matthew; Kiertiburanakul, Sasisopin (2022). Brief Report: Mortality After Loss to Follow-Up-A Linkage Study of People Living With HIV in Thailand and Malaysia, JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 91(3), 290-295. doi:10.1097/QAI.0000000000003067
  6. Kim, Jung Ho; Jiamsakul, Awachana; Kiertiburanakul, Sasisopin; Bui Vu Huy; Khusuwan, Suwimon; Kumarasamy, Nagalingeswaran; Ng, Oon Tek; Ly, Penh Sun; Lee, Man-Po; Chan, Yu-Jiun; Gani, Yasmin Mohamed; Azwa, Iskandar; Avihingsanon, Anchalee; Merati, Tuti Parwati; Pujari, Sanjay; Chaiwarith, Romanee; Zhang, Fujie; Tanuma, Junko; Cuong Duy Do; Ditangco, Rossana; Yunihastuti, Evy; Ross, Jeremy; Choi, Jun Yong (2022). Patterns and prognosis of holding regimens for people living with HIV in Asian countries, PLOS ONE. 17(3). doi:10.1371/journal.pone.0264157
  7. Ong, Jen Yeung; Yee, Anne; Amer Nordin, Amer Siddiq; Danaee, Mahmoud; Azwa, Raja Iskandar (2022). The prevalence of depression, anxiety and associated factors among adults with living human immunodeficiency virus in University Malaya Medical Centre, INTERNATIONAL JOURNAL OF STD & AIDS. . doi:10.1177/09564624221106528
  8. Papot, Emmanuelle; Jacoby, Simone; Arlinda, Dona; Avihingsanon, Anchalee; Azwa, Iskandar; Borok, Margaret; Brown, Dannae; Cisse, Mohamed; Dao, Sounkalo; Eriobu, Nnakelu; Kaplan, Richard; Karyana, Muhammad; Kumarasamy, Nagalingeswaran; Lee, Johnnie; Losso, Marcelo H.; Matthews, Gail, V; Perelis, Leonardo; Perez-Casas, Carmen; Ruxrungtham, Kiat; Watkins, Melynda; Lane, H. Clifford; Kelleher, Anthony; Law, Matthew; Polizzotto, Mark N. (2022). Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of (DEFT)-E-2, HIV RESEARCH & CLINICAL PRACTICE. 23(1), 37-46. doi:10.1080/25787489.2022.2103572
  9. Schaefer, Robin; Amparo da Costa Leite, Pedro Henrique; Silva, Ronaido; Karim, Quarraisha Abdool; Akolo, Christopher; Caceres, Carlos F.; Dourado, Ines; Green, Kimberly; Hettema, Anita; Hoornenborg, Elske; Jana, Smarajit; Kerschberger, Bernhard; Mahler, Holly; Matse, Sindy; McManus, Hamish; Molina, Jean-Michel; Reza-Paul, Sushena; Azwa, Iskandar; Shahmanesh, Maryam; Taylor, Doug; Vega-Ramirez, Hamid; Veloso, Valdilea G.; Baggaley, Rachel; Dalal, Shona (2022). Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data, LANCET HIV. 9(4), E242-E253. doi:10.1016/S2352-3018(22)00004-2
  10. Teeraananchai, Sirinya; Law, Matthew; Boettiger, David; De la Mata, Nicole; Gupte, Nikhil; Chan, Yun-ting Lawrence; Thach Ngoc Pham; Chaiwarith, Romanee; Penh Sun Ly; Chan, Yu-Jiun; Kiertiburanakul, Sasisopin; Khusuwan, Suwimon; Zhang, Fujie; Yunihastuti, Evy; Kumarasamy, Nagalingeswaran; Pujari, Sanjay; Azwa, Iskandar; Somia, I. Ketut Agus; Tanuma, Junko; Ditangco, Rossana; Choi, Jun Yong; Ng, Oon Tek; Cuong Duy Do; Gani, Yasmin; Ross, Jeremy; Jiamsakul, Awachana (2022). Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia, JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 25(8). doi:10.1002/jia2.25989
  11. Han, W. H., Yong, J. Y., Yong, S. S., Faheem, N. A. A., Toh, Y. F., Chew, M. F., . . . Azwa, I. (2021). Cutaneous manifestations of patients with Human Immunodeficiency Virus (HIV) Infection: A retrospective review of a tertiary referral centre with clinicopathological correlation. Australasian Journal of Dermatology, 62(3), 286-291. doi: 10.1111/ajd.13580
  12. Rajaram, Ruveena; Puvanendran, Nisha; Lee, Wai-Kin; Prasad, Ram; Omar, Sharifah Faridah Syed; Ponnampalavanar, Sasheela; Wong, Pui-Li; Basri, Sazali; Azwa, Raja Iskandar Shah Raja; Sulaiman, Helmi; Kukreja, Anjanna; Ng, Rong-Xiang; Johari, Bushra Megat; Ong, Hang-Cheng; Mahadeva, Sanjiv (2021). COVID-19 and liver dysfunction: Preliminary data from a single centre in Malaysia, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 36, 272-273
Others
  1. Han WM, Bijker R, Chandrasekaran E, Pujari S, Ng OT, Ly PS, Lee MP, Van Nguyen K, Chan YJ, Do CD, Choi JY, Chaiwarith R, Merati TP, Kiertiburanakul S, Azwa I, Khusuwan S, Zhang F, Gani YM, Tanuma J, Sangle S, Ditangco R, Yunihastuti E, Ross J, Avihingsanon A. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):489-497
  2. Han WM, Jiamsakul A, Jantarapakde J, Yunihastuti E, Choi JY, Ditangco R, Chaiwarith R, Sun LP, Khusuwan S, Merati TP, Do CD, Azwa I, Lee MP, Van Nguyen K, Chan YJ, Kiertiburanakul S, Ng OT, Tanuma J, Pujari S, Zhang F, Gani YM, Sangle S, Ross J, Kumarasamy N; the TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV. HIV Med. 2020 Nov 17.
  3. Mohamed AK, Raja IA, Rukumani DV. An epidemiological study of syphilis and predictors of treatment failure in University Malaya Medical Centre. Med J Malaysia. 2020 May;75(3):199-203
  4. Ross J, Jiamsakul A, Kumarasamy N, Azwa I, Merati TP, Do CD, Lee MP, Ly PS, Yunihastuti E, Nguyen KV, Ditangco R, Ng OT, Choi JY, Oka S, Sohn AH, Law M. Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific. HIV Med. 2020 Nov 5.
  5. Shrestha R, Galka JM, Azwa I, Lim SH, Guadamuz TE, Altice FL, Wickersham JA. Willingness to Use HIV Self-Testing and Associated Factors Among Transgender Women in Malaysia. Transgend Health. 2020 Sep 2;5(3):182-190.
  6. Yunihastuti E, Teeratakulpisarn N, Jeo WS, Nilasari H, Rachmadi L, Somia IKA, Sukmawati MDD, Amijaya KAT, Yee IA, Hairunisa N, Hongchookiat P, Trachunthong D, Pankam T, Nonenoy S, Ramautarsing R, Azwa I, Merati TP, Phanuphak P, Phanuphak N, Palefsky JM. Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women. AIDS. 2020 Nov 1;34(13):1933-1941.
  7. Lavinya, AA; Lee, CS; Hashim, OH; Azwa, I; Rajasuriar, R; Lim, SK; Wong, YF 2019. Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease. CLINICAL BIOCHEMISTRY
  8. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study. Pham MD1,2, Haile BA3,2, Azwa I4, Kamarulzaman A4, Raman N4, Saeidi A5, Kahar Bador M4, Tan M4, Zhu J6, Feng Y6, Elliott JH2, Garcia ML3, Li F3, Crowe SM3,2, Luchters S#3,2,7,8, Anderson DA#3,6.
  9. Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease. Lavinya AA1, Lee CS2, Hashim OH3, Azwa I4, Rajasuriar R5, Lim SK6, Wong YF7.
  10. Trends in mortality among ART treated HIV infected adults in the Asia Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia Pacific In Young Jung, 1 , 2 Dhanushi Rupasinghe, 3 Ian Woolley, 4 , 5 Catherine C O'Connor, 3 , 6 , 7 Michelle Giles, 5 Raja ISR Azwa, 8 Jun Yong Choi,corresponding author 2 , 9 and IeDEA Asia Pacific
  11. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. Boyd, MA; Amin, J; Mallon, PWG; Kumarasamy, N; Lombaard, J; Wood, R; Chetchotisakd, P; Phanuphak, P; Mohapi, L; Azwa, I; Belloso, WH; Molina, JM; Hoy, J; Moore, CL; Emery, S; Cooper, DA 2017. LANCET HIV
  12. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord; AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. Clin Infect Dis. 2017 Oct 15;65(8):1316-1326. doi: 10.1093/cid/cix480. PMID: 28531260
  13. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. Yap SH1, Abdullah NK1, McStea M1, Takayama K2, Chong ML1, Crisci E3, Larsson M3, Azwa I1,4, Kamarulzaman A1,4, Leong KH5, Woo YL1,6, Rajasuriar R1,5,7. PLoS One. 2017 Oct 9;12(10):e0186000. doi: 10.1371/journal.pone.0186000. eCollection 2017.
  14. Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. Rajasuriar R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, Mcstea M, Lee ECY, Wong PL, Azwa I, Syed Omar SF, Lai PSM, Ponampalavanar S, Crowe SM, Lewin SR, Kamaruzzaman SB, Kamarulzaman A. AIDS. 2017 Jun 19;31(10):1393-1403. doi: 10.1097/QAD.0000000000001475.
  15. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Cahn P1, Kaplan R2, Sax PE3, Squires K4, Molina JM5, Avihingsanon A6, Ratanasuwan W7, Rojas E8, Rassool M9, Bloch M10, Vandekerckhove L11, Ruane P12, Yazdanpanah Y13, Katlama C14, Xu X15, Rodgers A15, East L15, Wenning L15, Rawlins S15, Homony B15, Sklar P15, Nguyen BY15, Leavitt R15, Teppler H16; ONCEMRK Study Group. Cahn PE, Cassetti I, Losso M, Bloch MT, Roth N, McMahon J, Moore RJ, Smith D, Clumeck N, Vanderkerckhove L, Vandercam B, Moutschen M, Baril J, Conway B, Smaill F, Smith G, Rachlis A, Walmsley SL, Perez C, Wolff M, Lasso MF, Chahin CE, Velez JD, Sussmann O, Reynes J, Katlama C, Yazdanpanah Y, Ferret S, Durant J, Duvivier C, Poizot-Martin I, Ajana F, Rockstroh JK, Faetkanheuer G, Esser S, Jaeger H, Degen O, Bickel M, Bogner J, Arasteh K, Hartl H, Stoehr A, Rojas EM, Arathoon E, Gonzalez LD, Mejia CR, Shahar E, Turner D, Levy I, Sthoeger Z, Elinav H, Gori A, Monforte AD, Di Perri G, Lazzarin A, Rizzardini G, Antinori A, Celesia BM, Maggiolo F, Chow TS, Lee C, Azwa RISR, Mustafa M, Oyanguren M, Castillo RA, Hercilla L, Echiverri C, Maltez F, da Cunha JS, Neves I, Teofilo E, Serrao R, Nagimova F, Khaertynova I, Orlova-Morozova E, Voronin E, Sotnikov V, Yakovlev AA, Zakharova NG, Tsybakova OA, Botes ME, Mohapi L, Kaplan R, Rassool MS, Arribas JR, Gatell JM, Negredo E, Ortega E, Troya J, Berenguer J, Aguirrebengoa K, Antela A, Calmy A, Cavassini M, Rauch A, Stoeckle M, Sheng WH, Lin HH, Tsai HC, Changpradub D, Avihingsanon A, Kiertiburanakul S, Ratanasuwan W, Nelson MR, Clarke A, Ustianowski A, Winston A, Johnson MA, Asmuth DM, Cade J, Gallant JE, Ruane PJ, Kumar PN, Luque AE, Panther L, Tashima KT, Ward D, Berger DS, Dietz CA, Fichtenbaum C, Gupta S, Mullane KM, Novak RM, Sweet DE, Crofoot GE, Hagins DP, Lewis ST, McDonald CK, DeJesus E, Sloan L, Prelutsky DJ, Rondon JC, Henn S, Scarsella AJ, Morales JO, Ramirez, Santiago L, Zorrilla CD, Saag MS, Hsiao CB. Lancet HIV. 2017 Nov;4(11):e486-e494. doi: 10.1016/S2352-3018(17)30128-5. Epub 2017 Sep 11.
  16. Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia: findings from a qualitative study. Lim SH, Mburu G, Bourne A, Pang J, Wickersham JA, Wei CKT, Yee IA, Wang B, Cassolato M, Azwa I. J Int AIDS Soc. 2017 Aug 2;20(1):1-7. doi: 10.7448/IAS.20.1.21899.
  17. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey. Lim SH, Mburu G, Bourne A, Pang J, Wickersham JA, Wei CKT, Yee IA, Wang B, Cassolato M, Azwa I. PLoS One. 2017 Sep 13;12(9):e0182838. doi: 10.1371/journal.pone.0182838. eCollection 2017. PMID: 28902857
  18. Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD. Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD). Trop Med Int Health. 2016 May;21(5):662-74. doi: 10.1111/tmi.12690. Epub 2016 Mar 29. PMID: 26950901
  19. Human papillomavirus 16 (HPV16) and HPV52 E6-Specific Immunity in HIV-Infected Adults on combination Antiretroviral Therapy. Leng CY1, Low HC1, Chua LL2, Chong ML1, Sulaiman H1,3, Azwa I1,3, Roberts JM4, Kamarulzaman A1,3, Rajasuriar R1,5,6, Woo YL1,2,7. HIV Med. 2017 May;18(5):321-331. doi: 10.1111/hiv.12432. Epub 2016 Sep 20.
  20. The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database. Jiamsakul A, Kerr SJ, Chandrasekaran E, Huelgas A, Taecharoenkul S, Teeraananchai S, Wan G, Ly PS, Kiertiburanakul S, Law M; TREAT Asia HIV Observational Database (TAHOD). J Clin Epidemiol. 2016 Aug;76:183-92. doi: 10.1016/j.jclinepi.2016.01.030. Epub 2016 Feb 4. PMID: 26854260
  21. Efficacy of 2nd line second-line antiretroviral therapy among people living with HIV/AIDS in Asia: Results from the TREAT Asia HIV Observational Database. Boettiger DC, Nguyen VK, Durier N, Bui HV, Heng Sim, Benedict Lim; Azwa I, Law M, Ruxrungtham K Biostatistics and Databases Program, The Kirby Institute, UNSW Australia, Sydney, Australia; National Hospital of Tropical Diseases, Hanoi, Vietnam; TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand; Infectious Diseases Unit, Department of Medicine, Hospital Sungai Buloh, Sungai Buloh, Malaysia; Faculty of Medicine, Infectious Diseases Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia; and HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand. J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):186-95. doi: 10.1097/QAI.0000000000000411.
  22. HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD). Han N, Wright ST, O'Connor CC, Hoy J, Ponnampalavanar S, Grotowski M, Zhao HX, Kamarulzaman A; Australian HIV Observational Database (AHOD); TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2015 Mar;16(3):152-60. doi: 10.1111/hiv.12188. Epub 2014 Nov 18. PMID: 25407085
  23. Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92. doi: 10.1097/QAI.0000000000000634. PMID: 25850606
  24. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, F tkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD.Rappoport C, Aagaard PD, Collins S, Corbelli GM, Geffen N, Kittitrakul C, Maynard T, Meulbroek M, Munroe D, Nsubuga MS, Peavey D, Schwarze S, Valdez M, Baker JV, Duprez D, Carr A, Hoy J, Dolan M, Telenti A, Grady C, Matthews G, Rockstroh J, Belloso WH, Kagan JM, Wright E, Brew B, Price RW, Robertson K, Cysique L, Kunisaki KM, Connett JE, Niewoehner DE, Lifson A, Belloso WH, Davey RT Jr, Duprez D, Gatell JM, Hoy J, Pedersen C, Price RW, Prineas R, Worley J, Brekke K, Meger S, Baugh B, Eckstrand J, Gallagher C, Myers J, Rooney J, Van Wyk J, Baxter J, Carey C, DuChene A, Finley EB, George M, Grarup J, Hoover M, Pedersen R, Russell C, Standridge B, Flowers E, Hoover M, Smith K, McGrath M, Silver S, Soliman EZ, Barr M, Campbell C, Hensley S, Hu J, Keasler L, Li Y, Taylor T, Zhang ZM, Alston-Smith B, DeCarlo E, Klingman K, Proschan M, Bangdiwala S, Chaisson R, Fleischman AR, Hill C, Hilton J, Leite OH, Mathan VI, Pick B, Seas C, Suwangool P, Thimothe G, Venter F, Weller I, Yeni P, Neaton JD, Brekke K, Collins G, Denning ET, DuChene A, Engen NW, George M, Grund B, Harrison M, Hullsiek KH, Klemme LH, Krum E, Larson G, Meger S, Nelson R, Nordwall J, Quan K, Quan SF, Schultz T, Sharma S, Thompson G, Lundgren JD, Aagaard B, Borges AH, Eid M, Grarup J, Jansson P, Joensen Z, Nielsen B, Pearson M, Pedersen R, Phillips AN, Emery S, Berthon-Jones N, Carey C, Cassar L, Clewett M, Courtney-Rodgers D, Findlay P, Hough S, Jacoby S, Levitt J, Pett SL, Robson R, Shahamat V, Shambrook A, Babiker AG, Angus B, Arenas-Pinto A, Bennett R, Braimah N, Dennis E, Doyle N, Gabriel M, Hudson F, Jackson B, Palfreeman A, Paton N, Purvis C, Russell C, Gordin F, Conwell D, Elvis H, Finley EB, Kan V, Lynch L, Royal J, S nchez A, Standridge B, Thomas D, Turner M, Vjecha MJ, Losso MH, Lupo S, Marconi L, Aguila D, Lopardo G, Bissio E, Fridman D, Mingrone H, Loiza E, Mingrone V, Losso M, Bruguera JM, Burgoa P, Warley E, Tavella S, Belloso W, Sanchez M, Laplum H, Daciuk L, David D, Crinejo A, Rodriguez-Loria G, Doldan L, Moricz A, Otegui I, Lanusse I, Hoy J, Doong N, Hewitt S, Tee BK, Baker D, Odgers E, Agrawal S, Bloch M, Read TR, Kent SJ, Lau H, Roth N, Daly L, Shaw D, French M, Robinson J, Kelly M, Rowling D, Cooper DA, Kelleher A, Pell C, Dinning S, Hoy J, Costa J, Dwyer DE, King P, Rieger A, Vetter N, Schmied B, Rieger A, Touzeau VR, de Witt S, de Witt S, Clumeck N, Kabeya K, Cleve E, Florence E, van Petersen L, Ceunen H, van Wijngaerden EH, James T, Vandekerckhove L, Pereira LC Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20. PMID: 26192873
  25. Photo quiz. A painful and disfiguring lesion on the face. Sulaiman H, Ismail I, Azwa I, Jayalakshmi P, Bick J. Clin Infect Dis. 2015 Mar 15;60(6):928-9, 966-7. doi: 10.1093/cid/ciu973. PMID: 25733590
  26. Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. Study Group Lundgren J, Babiker A, Gordin F, Emery S, F tkenheuer G, Molina JM, Wood R, Neaton JD, RIS Raja Azwa. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, F tkenheuer G, Molina JM, Wood R, Neaton JD, Babiker AG, Gordin FM, Lundgren JD, Agan BK, Alston-Smith B, Arenas-Pinto A, Arribas JR, Baker JV, Baxter J, Belloso WH, Brekke K, Brew B, Brobst SW, Burman W, Carey C, Clark R, Cooper DA, Davey RT Jr, De La Rosa G, Denning ET, Dolan M, Dore G, Duprez D, Emanuel E, Emery S, F tkenheuer G, Grady C, Grund B, Hirschel B, Hoen B, Hudson F, Johnson MA, Kambili C, Klingman K, Kunisaki KM, Landay A, Ledergerber B, Lehrman SN, Martinez A, Meger S, Misar K, Mitsuyasu RT, Mocroft A, Molina JM, Munroe D, Norton M, Palmer RC, Pett SL, Phillips A, Pillay D, Porter D, Price RW, Proschan M, Rappoport C, Reiss P, Renjifo B, Robertson K, Rockstroh J, Rodriguez G, Rooney JF, Ross MJ, Schechter M, Schwarze S, Seekins D, Sharma S, Snowden W, Telenti A, Tryon J, van Wyk J, Vjecha MJ, Wright E, Baker JV, Duprez D, Carr A, Hoy J, Dolan M, Telenti A, Grady C, Matthews G, Rockstroh J, Belloso WH, Kagan JM, Wright E, Brew B, Price RW, Robertson K, Kunisaki KM, Connett JE, Niewoehner DE, Rappoport C, Aagaard PD, Collins S, Condon J, Corbelli GM, Geffen N, Meulbroek M, Munroe D, Nsubuga MS, Peavey DE, Schwarze S, Tienudom N, Valdez M, Watson J, Lifson A, Belloso WH, Davey RT Jr, Duprez D, Gatell JM, Hoy J, Mitsuyasu RT, Pedersen C, Price RW, Prineas R, Worley J, McBurnett S, Eckstrand J, Flowers E, Hoover M, Smith K, McGrath M, Silver S, Barr M, Campbell C, Hensley S, Hu J, Keasler L, Li Y, Soliman EZ, Taylor T, Zhang ZM, Alston-Smith B, DeCarlo E, Klingman K, Brekke K, Collins G, Denning ET, DuChene A, Engen NW, George M, Grund B, Harrison M, Hullsiek KH, Krum E, Meger S, Nelson R, Neuhaus J, Quan K, Quan SF, Schultz T, Sharma S, Thompson G, Aagaard B, Borges AH, Eid M, Grarup J, Jansson P, Joensen Z, Lundgren J, Nielsen B, Pearson M, Pedersen R, Peters L, Carey C, Cassar L, Cooper DA, Courtney-Rodgers D, Emery S, Evans M, Hough S, Jacoby S, Levitt J, Robson R, Seneviratne N, Shambrook A, Angus B, Arenas-Pinto A, Babiker A, Bennett R, Braimah N, Dennis E, Doyle N, Gabriel M, Hudson F, Jackson B, Palfreeman A, Popoola B, Russell C, Conwell D, Elvis H, Finley E, Gordin FM, Kan V, Lynch L, Royal J, S nchez A, Standridge B, Thomas D, Turner M, Vjecha MJ, Bissio E. HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227.
  27. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. ENCORE1 Study Group, Carey D, Puls R, Amin J, Losso M, Phanupak P, Foulkes S, Mohapi L, Crabtree-Ramirez B, Jessen H, Kumar S, Winston A, Lee MP, Belloso W, Cooper DA, Emery S. Collaborators (96) Amin J, Becker S, Belloso W, Boffito M, Cooper D, Crabtree-Ramirez B, Duncombe C, Emery S, Foulkes S, Hill A, Jessen H, Kumar S, Lee MP, Losso M, Nwizu C, Phanuphak P, Read T, Rooney J, Schaffer K, Shahar E, Winston A, Wolff M, Young B, Abela C, Amin J, Avihingsanon A, Belloso W, Boyd M, Carey D, Clarke A, Cooper D, Courtney-Vega K, Delfino M, Donaldson A, Emery S, Espinosa N, Johannesen T, Lin E, Losso M, Moricz A, Pett S, Phanupak P, Puls R, Pussadee K, Sutheerasak P, Tomlins L, Ubolyam S, Belloso W, Azwa RI, Bissio E, Calanni L, Chetchotisakd P, Cooper D, Crabtree-Ramirez B, Doong N, Elliott J, Foulkes S, Gazzard B, Jessen H, Kelly M, Kumar S, Laplume H, Lee MP, Losso M, del Carmen Luna N, Lupo S, Messina OG, Mohapi L, Moore R, Nolan D, Nwizu C, Orrell C, Perez C, Phanuphak P, Read T, Rockstroh J, Rowling D, Shahar E, Supparatpinyo K, Smith D, Villanueva JA, Vlahakis E, Winston A, Wolff M, Young B, Kelleher T, Cunningham P, Merlin K, Yeung J, Shaik A, Fsadni B, Carrera A, Lograsso M, Gulick R, Dunn D, Dolan M. [Lancet Infect Dis. 2015] Lancet Infect Dis. 2015 Jul;15(7):793-802. doi: 10.1016/S1473-3099(15)70060-5. Epub 2015 Apr 12.
  28. Ong, L. Y., Razak, S. N. H., Lee, Y. M., Sri La Sri Ponnampalavanar, S., Syed Omar, S. F., Azwa, R. I., ... & Kamarulzaman, A. (2014). Molecular diversity of HIV 1 and surveillance of transmitted drug resistance variants among treatment Na ve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. Journal of medical virology, 86(1), 38-44.
  29. Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study. Achhra AC, Pujari S, Choi JY, Khusuwan S, Kinh NV, Phanuphak P, Chaiwarith R, Lee MP, Saphonn V, Kiertiburanakul S, Thuy PT, Law MG; TREAT Asia HIV Observational Database (TAHOD) Cohort. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):e108-11. doi: 10.1097/QAI.0000000000000217. PMID: 24853312
  30. Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells. Gu M, Yu Y, Gunaherath GM, Gunatilaka AA, Li D, Sun D. Invest New Drugs. 2014 Feb;32(1):68-74. doi: 10.1007/s10637-013-9987-y. Epub 2013 Jul 26. PMID: 23887853
  31. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients. Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT, Durier N, Phanuphak P, Ditangco R, Chaiwarith R, Kantipong P, Lee CK, Mustafa M, Saphonn V, Ratanasuwan W, Merati TP, Kumarasamy N, Wong WW, Zhang F, Pham TT, Pujari S, Choi JY, Yunihastuti E, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD); TREAT Asia Studies to Evaluate Resistance (TASER). J Int AIDS Soc. 2014 Mar 14;17:18804. doi: 10.7448/IAS.17.1.18804. eCollection 2014. PMID: 24598459
  32. Human Immunodeficiency Virus (HIV) in Pregnancy: A Review of the Guidelines for Preventing Mother-to-Child Transmission in Malaysia. Azwa I, Khong SY. Ann Acad Med Singapore. 2012 Dec;41(12):587-94. Review. PMID: 23303117
  33. Elgalib A, Hegazi A, Samarawickrama A, Roedling S, Tariq S, Draeger E, Hemelaar J, Rathnayaka T, Azwa A, Hawkins D, Edwards S, Perez K, Russell J, Wood C, Poulton M, Shah R, Noble H, Rodgers M, Taylor GP, Anderson J, de Ruiter A. HIV Med. 2011 Feb;12(2):118-23. doi: 10.1111/j.1468-1293.2010.00878.x. PMID: 20807252
  34. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, Wong MH, Syed Omar SF, Hussain SH. J Infect. 2010 Nov;61(5):440-2. doi: 10.1016/j.jinf.2010.08.001. Epub 2010 Aug 11. PMID: 20708031
  35. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort. Vogel M, Dominguez S, Bhagani S, Azwa A, Page E, Guiguet M, Valantin MA, Katlama C, Rockstroh JK, Nelson M. Antivir Ther. 2010;15(2):267-79. doi: 10.3851/IMP1501. PMID: 20386082
  36. Aspects of Herpes Simplex Virus a clinical review Azwa A, Barton SE J Fam Plann Reprod Health Care. 2009 Oct;35(4):237-42. doi: 10.1783/147118909789587376. PMID: 19849918
  37. Scott C, Azwa A, Cohen C, McIntyre M, Desmond N. Int J STD AIDS. 2009 Aug;20(8):585-6. doi: 10.1258/ijsa.2008.008350. PMID: 19625597
  38. Azwa A, Nelson M, Sokwala A, Harania RS, Stebbing J AIDS. 2008 Jul 11;22(11):1374-6. doi: 10.1097/QAD.0b013e328303be50. PMID: 18580619
  39. Teo EC, Azwa A, Jones RL, Gazzard BG, Nelson M PMID: 17962793 Imperial College School of Medicine, London, UK. ecyteo@yahoo.co.uk

RESEARCH PROJECT


National
  1. 2021 - 2023, Partnership Grant
    Using A Popular Teletraining Platform To Reduce Clinician Stigma And Disparities In Hiv Testing, Prevention And Linkage To Care In Malaysia ( Co-Researcher)
  2. 2016 - 2017, UNAIDS
    Willingness to use HIV Pre-exposure prophylaxis among Men Who have sex with men in Malaysia ( Principal Investigator(PI))
  3. 2014 - 2015, Others MOHE
    Sexual Health Profile of the Aging HIV Population ( Principal Investigator(PI))
  4. 2011 - 2013, Others MOHE
    A Prospective Study Correlating Human Papilloma Virus (HPV) Carriage and its associated pathology with host immune factors in a Malaysian Cohort of HIV Positive Patients ( Consultant)
  5. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Prevalence of Syphilis and HIV amongst injecting drug users attending a community needle syringe exchange drop-in centre ( Principal Investigator(PI))
International
  1. 2022 - 2025, International Funding
    Improving Hiv Testing And Prep For Transgender Women Through Mhealth ( Principal Investigator(PI))
  2. 2022 - 2025, International Funding
    Gamification To Enhance Engagement In Hiv Prevention And Co-morbid Conditions In Young Men Who Sex With Men ( Principal Investigator(PI))
  3. 2019 - 2021, International Funding
    Body Composition Sub-study of D2EFT ( Principal Investigator(PI))
  4. 2020 - 2021, International Funding
    IeDEA Asia-Pacific Research Collaboration: TREAT Asia HIV Observational Database including NCD Data ( Principal Investigator(PI))
  5. 2019 - 2020, International Funding
    IeDEA Asia-Pacific Research Collaboration: TREAT Asia HIV Observational Database (TAHOD) including NCD Data ( Principal Investigator(PI))
  6. 2018 - 2020, International Funding
    My PrEP Study: A Pilot HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project in high risk Men who have sex with Men (MSM) in Kuala Lumpur ( Principal Investigator(PI))
  7. 2016 - 2018, Private Funding
    TASER-2 - Cross sectional study of resistance associated mutations in patients experiencing virological failure on 2nd line ART ( Principal Investigator(PI))
  8. 2016 - 2017, Private Funding
    Resistance to Second-line Antiretroviral Therapy in HIV-Infected Adults in Asia ( Principal Investigator(PI))
  9. 2016 - 2017, Private Funding
    Showing Up Late: Understanding the delay in treament seeking among people with HIV in Malaysia ( Principal Investigator(PI))
  10. 2016 - 2016, Private Funding
    Evaluation of a novel filter-based paper method of plasma separation for HIV viral load testing ( Principal Investigator(PI))
  11. 2014 - 2015, Private Funding
    Reformulated Once Daily Raltegravir Study in ART naive patients ( Principal Investigator(PI))
  12. 2014 - 2015, Private Funding
    The prevelance and incidence of anal human papillomavirus (HPV) infection and high grade anal intrepithelial neoplasia (HGAIN) among men who have sex with men (MSM) ( Principal Investigator(PI))
  13. 2013 - 2015, Private Funding
    Strategic Timing od Antiretroviral treatment (START) ( Principal Investigator(PI))
  14. 2013 - 2014, Private Funding
    The evaluation of Point Of Care (POC) CD4 count testing using the Alere PIMA CD4 test in the management of people living with HIV in a tertiary HIV referral centre ( Principal Investigator(PI))
  15. 2012 - 2013, Private Funding
    Prevalence and correlates of HIV, syphilis and hepatitis B infections in high risk men who have sex with men (MSM) in Kuala Lumpur ( Principal Investigator(PI))
  16. 2011 - 2012, Private Funding
    ENCORE 1 Study. A randomized, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) and standard dose EFV plus two nucleotide reverse transcriptase inhibitors in antiretroviral-naive HIV infected individuals over 96 weeks ( Principal Investigator(PI))

PAPER PRESENTED


PLENARY SPEAKER
  1. The Art of Initiating ART, 22nd Bangkok International Symposium of HIV Medicine 2020, HIV NAT (International) (15 Jan 2020 - 17 Jan 2020)
INVITED SEMINAR
  1. HIV & AIDS : The Current Situation in Malaysia , The Annual Gathering of The Great Minds (GOTGM), Society of MMA Medical Students (SMMAMS) (University) (23 Mar 2019 - 23 Mar 2019)
INVITED SPEAKER
  1. The Next Step: What to after failing 1st line antiretroviral treatment (ART), Universiti Malaya HIV/STI Updates, Infectious Disease Unit, Universiti Malaya (National) (21 Oct 2023 - 21 Oct 2023)
  2. Practical & Clinical Considerations of Implementing Long Acting ART, Innovations in HIV Therapeutics 2023, Academic Medical Education (International) (15 Aug 2023)
  3. Can LA-ART improve Quality of Life?, Clinical Care Options (CCO) Satellite Symposium, International AIDS Society (IAS) 2023 Conference (International) (25 Jul 2023 - 25 Jul 2023)
  4. Implementation Science and Young Men who Have Sex with Men, Universiti Malaya-Yale University MIST Summer Bootcamp 2023, Universiti Malaya - Yale University (National) (17 Jul 2023 - 19 Jul 2023)
  5. PrEP Should be Made Available Without a Prescription in the Asia-Pacific Region: Pro Standpoint, Asia-Pacific AIDS & Co-Infections Conference (APACC) 2023, American Medical Education (International) (08 Jun 2023 - 10 Jun 2023)
  6. The role of Nucleosides in Second Line HIV Treatment, Asia-Pacific AIDS & Co-Infections Conference (APACC) 2023, Academic Medical Education (International) (08 Jun 2023 - 10 Jun 2023)
  7. Long Acting (LA) HIV Pre-exposure prophylaxis (PrEP): The Science and community perception, Post Trial Responsibilities And Access to Injectable Cabotegravir for PrEP, Hot Topics in Research Ethics Webinar, Master of Health Research Ethics (MOHRE) Programme, Universiti Malaya- Joh Hopkins University (International) (10 Apr 2023 - 10 Apr 2023)
  8. HIV & Opportunistic Infections, Tropical Medicine Workshop, Universiti Malaya - University of Glasgow (University) (24 Feb 2023 - 24 Feb 2023)
  9. HIV Pre-Exposure Prophylaxis (PrEP) Updates for the Infectious Disease (ID) Physician, International Congress on Infectious Diseases (ICID) 2022, International Society for Infectious Diseases (ISID) (International) (18 Nov 2022 - 18 Nov 2022)
  10. Latest scientific updates on HIV treatment, International AIDS Society (IAS) Educational Fund Workshop, International AIDS Society (International) (09 Nov 2022 - 10 Nov 2022)
  11. What is new in the HIV Pre-Exposure (PrEP) Guidelines?, My HIV Forum 2022, Malaysian HIV Association (MASHM) & Malaysian AIDS Council (National) (16 Oct 2022 - 16 Oct 2022)
  12. Track C (Epidemiology & Prevention Science) Rapporteur Highlights, AIDS 2022, 24th International AIDS Conference, International AIDS Society (International) (02 Aug 2022 - 02 Aug 2022)
  13. Long Acting Antiretroviral treatment (ART): Will all populations benefit?, AIDS 2022, 24th International AIDS Conference, The International AIDS Society (International) (29 Jun 2022 - 02 Aug 2022)
  14. Intersection of Stigma and U=U: The Clinician s Perspective, Chinese HIV Clinical Forum Educational Series 2021, Patient Directed Care, Virology Education (International) (22 Feb 2022 - 22 Feb 2022)
  15. The My PrEP Study - Lessons learnt from a pilot demonstration project and recommendations for scale up, IAS Educational Fund Virtual Meeting, International AIDS Society (IAS) (International) (03 Dec 2020 - 03 Dec 2020)
  16. Implementation of PrEP- Social Aspects and Risk Compensation, Asia-Pacific HIV Clinical Forum 2020 , Virology Education (International) (12 Oct 2020 - 13 Oct 2020)
  17. "Updates in 1st and 2nd Line regimens", IAS Educational Fund meeting in Malaysia 2019, IAS Educational Fund International AIDS Society (International) (04 Oct 2019 - 05 Oct 2019)
  18. Same-day ART should be implemented in HIV treatment programs in the Asia-Pacific Pro standpoint, 4th Asia Pacific AIDS & Co-Infections Conference (APACC 2019), APACC (International) (28 Jun 2019 - 28 Jun 2019)
  19. Best Antiretroviral treatment (ART) Regimen for Same Day ART Service, 21st Bangkok International Symposium on HIV Medicine , HIV-NAT (International) (16 Jan 2019 - 18 Jan 2019)
KEYNOTE SPEAKER
  1. Next Generation of Sexually Transmitted Infection (STI) prevention, 2023 Asia-Pacific Chemsex Symposium, HIV Education & Research Taiwan (HEArT) (International) (26 Oct 2023 - 26 Oct 2023)
OTHERS
  1. " Access to ARV 2.0", IAS Educational Fund Meeting , IAS Educational Fund International AIDS Society  (International) (04 Oct 2019 - 05 Oct 2019)
  2. PrEP/HIV Self Testing Session, IAS Educational Fund Workshop, International AIDS Society  (International) (04 Oct 2019 - 05 Oct 2019)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2024) Re-Review of Manuscript No: Aids-D-23-00490r1 Title: Treatment Outcomes Among Older Hiv/Aids Patients Receiving Antiretroviral Therapy: a Nine-Year Retrospective Study, International, (Reviewer)
  2. (2023) Reviewer of Manuscript No: Aids-D-23-00490r1 Tiltle: Treatment Outcomes Among Older Hiv/Aids Patients Receiving Antiretroviral Therapy: a Nine-Year Retrospective Study, International, (Reviewer)
  3. (2023) External Reviewer of Updated 2023 Malaysian Sexually Transmitted Infection (Sti) Guidelines (5th Edition), National, (Reviewer)
  4. (2023) Reviewer of Manuscript No: Aids-D-23-00206 Title: Vaccination of Men Who Have Sex With Men Against Mpox and Their Differential Risk of Exposure and Infection by Hiv Status, International, (Reviewer)
  5. (2023) Reviewer of Manuscipt No: Aids-D-23-00153 " Preference for Daily Oral Pills Over Long-Acting Antiretroviral Therapy Options Among People With Hiv", International, (Reviewer)
  6. (2023) Chairperson and Assessor for Phd Student Proposal Defence, Thesis Title: Endurance : Implementation of Depression and Substance Use Screening and Linkage to Care in An Infectious Disease Clinic of a Tertiary-Care Hospital in Malaysia, University, (Internal Examiner)
  7. (2022) Reviewer of Manuscript Id: Jias-2022-10-0607 "Pharmacy Delivery of Daily Oral Hiv Pre-Exposure Prophylaxis in Kenya", International, (Reviewer)
  8. (2022) Reviewer of Manuscript No: Aids-D-22-00653 Title: Viral Suppression Among Adults With Hiv Receiving Routine Dolutegravir-Based Antiretroviral Therapy and 3hp, International, (Reviewer)
  9. (2022) Reviewer of Manuscript Reference Number: Aids-D-22-00564 Title: Impact of Rilpivirine Cross-Resistance On Long-Acting Cabotegravir-Rilpivirine in Low and Middle Income Countries, International, (Reviewer)
  10. (2022) Internal Examiner of The Clinical Long Case Examination of Part 2 of The Internal Medicine Master's Degree Program (Conjoint) October 2022 Session, University, (Internal Examiner)
  11. (2022) Panel Reviewer Dom-Rsf Fund Research Grant 2022, University, (Reviewer)
  12. (2022) Reviewer of Manuscript Reference Number: Aids-D-22-00514 Title: Impact of Screening Program to Prevent Anal Cancer in High-Risk Patients With Human Immunodeficiency Virus, International, (Reviewer)
  13. (2022) Examiner for Modified Long Case for Ummp 3.3 End of Posting Examination, University, (Internal Examiner)
  14. (2022) Modified Long Case Examiner for Ummp Stage 3.3 End of Posting J Examination, University, (Internal Examiner)
  15. (2022) Reviewer of Manusctipt No: Aids-D-22-00162 "Impact of Pre-Existing Nrti Resistance On The Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data", International, (Reviewer)
  16. (2022) External Reviewer of Who Guidelines On Long- Acting Injectable Cabotegravir for Hiv Prevention., International, (Reviewer)
  17. (2022) Reviewer of Manuscript Reference Number: Aids-D-21-00889 Title: Hptn 078: An Enhanced Case Management Rct to Achieve Viral Suppression Among Viremic Hiv-Positive Msm in The Us, International, (Reviewer)
  18. (2020) Reviewer of Manuscript reference number: AIDS-D-20-00023 Title: Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status Journal: AIDS , (Reviewer)
  19. (2020) Reviewer of Manuscript reference number: AIDS-D-20-00907 Title: ASIL and Anal Cancer in PLWH: Update in Era of ART Journal: AIDS , (Reviewer)
  20. (2020) Reviewer of Manuscript reference number: AIDS-D-20-00567 Title: Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection. Journal: AIDS , (Reviewer)
  21. (2020) Abstract reviewer for AIDS 2020, (Reviewer)
  22. (2019) Abstract Reviewer for the 10th IAS Conference on HIV Science (IAS 2019), Mexico City, Mexico , (Reviewer)
  23. (2018) Review manuscript MJM-D-18-00131 for The Medical Journal of Malaysia, (Reviewer)
Contribution to external organisation
  1. (2024) President of Malaysian Aids Council, National, (Resource Person)
  2. (2023) Guidelines Development Group (Gdg) for The Development of Who Guidelines On Hiv Post-Exposure Prophylaxis, International, (Expert Advisor)
  3. (2023) Regional Advisory Group Member On Blood Borne Viruses (Bbv) and Covid-19, International, (Expert Advisor)
  4. (2022) Health Care Professional Participant in a "Call to Action" Podcast On "What Patients Want in Hiv Treatment and Prevention", International, (Resource Person)
  5. (2022) Contributor to 2022 Update of Malaysian Consensus Guidelines On Hiv Therapy, National, (Expert Advisor)
  6. (2022) Chair of Treat Asia Hiv Observational Database (Tahod) Steering Committee, International, (Academic Appointment )
  7. (2020) Regional Advisory Group Member on Blood Borne Viruses (BBV) and COVID-19, Australian Society for HIV Medicine, Viral Hepatitis and Sexual Health Medicine (ASHM), International
  8. (2020) Update of WHO Clinical Recommendations for the Prevention of HIV and the Treatment and Care of People Living with HIV (PLHIV), 2020 Guidelines Development Group Meeting, 28 September 02 October 2020, World Health Organisation
Contribution to event
  1. (2023) Expert Faculty Member, Clinical Care Options (Cco) Symposium, 12th International Aids Society Conference On Hiv Science (IAS 2023), International, (Panelist/Moderator)
  2. (2023) Member of Epidemiology and Prevention Science Track (Track C) Organizing Committee, International, (Event Organiser)
  3. (2022) Chair in Innovations in Hiv Therapeutics Forum, Asia Pacific Edition, International, (Panelist/Moderator)
  4. (2022) Chairperson of Ummc World Aids Day Celebration, University, (Event Coordinator)
  5. (2022) Guest of Honour & Speaker At Taylor's University World Aids Day Event, University, (Participant)
  6. (2022) Deputy Chairperson, Organising Committee, My Hiv Forum 2022, National, (Event Organiser)
  7. (2022) Participant in Rountable Discussion On "What Patients Want in Hiv Treatment" On Clinical Care Options, International, (Panelist/Moderator)
  8. (2022) Chair, Plenary Session: Prep in Key Populations, International, (Panelist/Moderator)
  9. (2022) Panelist, How Do You Ensure Communications With Your Clients Are Stigma Free?, International, (Panelist/Moderator)
Media appearance
  1. (2023) Tatler Interview: Infectious Disease Authority Dr Raja Iskandar Shah Emphasises On Hiv Prevention and Treatment to Curtail Transmissions, National, (Interview)
  2. (2023) Codeblue Interview: Ummc Performs Ground Breaking Kidney Transplant On Person Living With Hiv, National, (Interview)
  3. (2022) Code Blue Interview On "Scaling Up of Hiv Pre-Exposure Prophylaxis (Prep) in The Public Sector, National, (Interview)

SUPERVISION


Postgraduate Student
PhD/ Doctoral
  1. (2023) IMPLEMENTATION OF A PHARMACIST-LED PRE-EXPOSURE PROPHYLAXIS (PrEP)SERVICE USING ELECTRONIC PRESCRIBING SYSTEM (EPS) FOR HIV PREVENTION IN MALAYSIA, YAN NEE GAN
  2. (2014) DETERMINANTS OF LATE PRESENTATION OF HIV PATIENTS TO PRIMARY CARE CENTRES IN NIGERIA, YUSUF ABDU MISAU
Master
  1. (2023) Effectiveness of Stigma Reduction Tools in a Tele-training Platform to Strengthen HIV Activism Among Clinicians, NORMAN CHONG
  2. (2022) A DEMONSTRATION PROJECT OF ANTIRETROVIRAL HIV PRE-EXPOSURE PROPHYLAXIS FOR MEN WHO HAVE SEX WITH MEN IN KLANG VALLEY, MALAYSIA, Mohd Akbar Ab Halim
  3. (2021) -, NUR ADILAH BINTI AWALUDIN
  4. (2020) The My PrEP Study: a pilot HIV PrEP demonstration project in high risk MSM in Kuala Lumpur, Mohd Akbar Ab Halim
  5. (2019) VIROLOGICAL AND METABOLIC OUTCOMES AND ADVERSE EVENTS ASSOCIATED WITH EFAVIRENZ-AND DOLUTEGRAVIR-BASED ANTIRETROVIRAL THERAPY IN HIV TREATMENT NAIVE INDIVIDUALS AT UMMC: A RETROSPECTIVE STUDY, LING CHUAN KAI
  6. (2018) PROTEOMICS ANALAYSIS OF BLOOD PLASMA OF HIV INFECTED PATIENTS WITH CHRONIC KIDNEY DISEASE, Amanda Anne Lavinya
  7. (2018) Examination of circulating proteins in plasma of HIV-infected patients with chronic kidney disease, AMANDA ANNE LAVINYA
  8. (2018) A PILOT DEMONSTRATION PROJECT OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG MEN WHO HAVE SEX WITH MEN IN KUALA LUMPUR, A COMMUNITY BASED ORGANIZATION APPROACH, Dr Sazali bin Basri
  9. (2018) -, TILAGAMATY A/P MURTHY
  10. (2017) AN EPIDEMIOLOGICAL STUDY OF SYPHILIS AND PREDICTORS OF TREATMENT FAILURE IN UNIVERSITY MALAYA MEDICAL CENTER (UMMC), MOHAMED AMIN BIN KADER NAINA MOHD
  11. (2016) SICK ROLE OR EMPOWERMENT: THE UNCERTAINTIES OF LIFE WITHIN AN HIV POSITIVE DIAGNOSIS, MATHAVI D/O NADARAJAH
Under Graduate Students
  1. (2021) , Dr Ng Rong Xiang

TEACHING


Master
  1. (2021) NA - Master of Internal Medicine (Mmed)Intensive Revision Course

SOCIAL RESPONSIBILITY ACTIVITIES


  • World Aids Day Organizer, (09 Nov 2017 - 09 Dec 2017)
  • World Aids Day Organizer, (01 Dec 2016 - 07 Dec 2016)